KATIE BOESZ: Open Payments
NPI 1760926778 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 28 payments from 9 companies in 2025. Trend: 2023 $1,562 · 2024 $1,199 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $206 |
| ABBVIE INC. | 6 | $118 |
| Amgen Inc. | 4 | $75 |
| Organon LLC | 3 | $63 |
| GENZYME CORPORATION | 2 | $40 |
| Lilly USA, LLC | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| LEO Pharma Inc. | 1 | $14 |
Products named: COSENTYX, SKYRIZI, OTEZLA, Rhapsido, VTAMA, DUPIXENT, RINVOQ, TALTZ.
Industry payments across NJ — which companies pay providers there.
